R.O.C.S. Becomes a New Client of FBK Grant Thornton

FBK Grant Thornton experts will perform valuation of intangible assets, namely R.O.C.S. promising medical inventions.

“We have a wide experience of working with medical innovations. The new task, in its turn, is interesting for us because the patents subject to valuation are also attractive to foreign investors,” Director of FBK Department of Valuation Stanislav Novikov noted.

DRC Group (R.O.C.S.) is a Russian company and one of the leading manufacturers of innovative oral care products, cosmetics, medical products, ingredients and pharmaceutical substances. The company has received more than 50 patents for products all over the world.